Modern Epidemiological Methods — MCQs
Match the following columns on Epidemiology Guidelines: | A. CARE | 1. RCT | | :-- | :-- | | B. CONSORT | 2. Case report | | C. PRISMA | 3. Observational study | | D. STROBE/MOOSE | 4. Systematic Review |
What is the first step an epidemiologist takes in an epidemic investigation?
A group of 80 people is being studied to determine the effect of diet modification on cholesterol levels. To compare the mean cholesterol levels before and after the diet modification in this group, which statistical test should be used?
Which study design is most effective for investigating rare adverse effects of a drug?
In dengue surveillance, indices that are commonly used to monitor Aedes aegypti infestation levels are all, EXCEPT:
Which of the following statements is true regarding a combined prospective-retrospective study?
Which of the following diseases shows the LEAST difference in incidence between rural and urban populations?
A town in the hills had a mid-year population of 250000 in the year 2021. During the same year, the death registry of the town recorded 1500 deaths due to tuberculosis in 365 calendar days. Given these facts, what is the specific death rate for tuberculosis in the town?
What is the chance of HIV infection after needle prick injury?
The incubation period does not help in determining which of the following?
Modern Epidemiological Methods Indian Medical PG Practice Questions and MCQs
Question 1: Match the following columns on Epidemiology Guidelines: | A. CARE | 1. RCT | | :-- | :-- | | B. CONSORT | 2. Case report | | C. PRISMA | 3. Observational study | | D. STROBE/MOOSE | 4. Systematic Review |
- A. A2-B1-C4-D3 (Correct Answer)
- B. A2-B4-C1-D3
- C. A4-B1-C3-D2
- D. A4-B1-C2-D3
Explanation: ***A2-B1-C4-D3*** - **CARE Guidelines** provide essential reporting standards for **case reports** and case series to enhance their value and transparency. - **CONSORT (Consolidated Standards of Reporting Trials)** is specifically designed for the reporting of **Randomized Controlled Trials (RCTs)**. - **PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses)** provides a minimum set of items for reporting in **systematic reviews** and meta-analyses. - **STROBE (STrengthening the Reporting of OBservational studies in Epidemiology)** and **MOOSE (Meta-analysis Of Observational Studies in Epidemiology)** are reporting guidelines for **observational studies**, including cohort, case-control, and cross-sectional studies. *A2-B4-C1-D3* - Incorrectly pairs CONSORT with systematic reviews (should be RCTs) and PRISMA with RCTs (should be systematic reviews). - CONSORT is the gold standard for **reporting RCTs**, while PRISMA is designed for **systematic reviews and meta-analyses**. *A4-B1-C3-D2* - Incorrectly matches CARE with systematic reviews, PRISMA with observational studies, and STROBE/MOOSE with case reports. - CARE is specifically for **case reports and case series**, PRISMA for **systematic reviews**, and STROBE/MOOSE for **observational epidemiological studies**. *A4-B1-C2-D3* - Incorrectly pairs CARE with systematic reviews and PRISMA with case reports. - This reverses the actual purpose: CARE is designed for **case reports**, while PRISMA guides **systematic reviews and meta-analyses**.
Question 2: What is the first step an epidemiologist takes in an epidemic investigation?
- A. Confirm the diagnosis (Correct Answer)
- B. Identify the prone people
- C. Identify the causative factors
- D. Identify the cases
Explanation: ***Confirm the diagnosis*** - The initial and most crucial step is to **confirm the diagnosis** of the disease in question to ensure that the reported cases are indeed suffering from the same condition. - This step helps to avoid misclassification and ensures the investigation focuses on a specific, confirmed health problem. *Identify the cases* - While essential, **identifying cases** usually follows initial diagnostic confirmation, as you need a clear case definition based on a confirmed diagnosis to correctly identify who is a case. - This involves defining who is considered a case based on symptoms, laboratory results, and epidemiological links. *Identify the prone people* - **Identifying prone people** refers to determining the population at risk, which is a subsequent step after understanding the confirmed disease and its initial pattern. - This step typically falls under characterizing the distribution of the disease (person, place, time) in the investigation. *Identify the causative factors* - **Identifying causative factors** is a later stage in the investigation, often involving analytical studies to test hypotheses, which can only occur effectively once the diagnosis is confirmed and cases are clearly defined and counted. - This step aims to understand *why* the epidemic is occurring, after establishing *what* is occurring.
Question 3: A group of 80 people is being studied to determine the effect of diet modification on cholesterol levels. To compare the mean cholesterol levels before and after the diet modification in this group, which statistical test should be used?
- A. Paired t-test (Correct Answer)
- B. McNemar test
- C. Chi-square test
- D. Wilcoxon signed-rank test
- E. Independent t-test
Explanation: ***Paired t-test*** - A **paired t-test** is appropriate for comparing means from two related samples, such as "before" and "after" measurements on the **same individuals**. - It assesses whether there is a statistically significant difference between these **dependent observations**. *Independent t-test* - The independent t-test compares means between **two separate groups** (unrelated samples). - It is inappropriate here because we have **paired data** from the same individuals measured twice, not two independent groups. *McNemar test* - The McNemar test is used for comparing **paired nominal data**, typically in a 2×2 table, for example, before-after changes in a proportion or categorical outcome. - It is not suitable for **continuous data** like cholesterol levels. *Chi-square test* - The chi-square test is used to assess the association between **two categorical variables** or to compare observed frequencies with expected frequencies. - It is not designed for comparing means of **continuous variables** in paired samples. *Wilcoxon signed-rank test* - The Wilcoxon signed-rank test is a **non-parametric alternative to the paired t-test**, used when the data are not normally distributed or when the sample size is small. - While it's used for paired data, the paired t-test is generally preferred when parametric assumptions (like **normality**) can be met, especially with a sample size of 80.
Question 4: Which study design is most effective for investigating rare adverse effects of a drug?
- A. Cohort study
- B. Cross-sectional study
- C. Case-control study (Correct Answer)
- D. Clinical trial/experimental study
Explanation: ***Case-control study*** - This design starts by identifying individuals with the **rare adverse effect (cases)** and a control group without the effect to look back for exposure to the drug. - It is efficient for studying rare outcomes because it doesn't require following a large population for a long time to observe few events. *Cohort study* - A **cohort study** follows a group of individuals exposed and unexposed to a drug forward in time to observe outcomes. - While good for common outcomes, it would require an **extremely large sample size** and a long follow-up period to observe rare adverse drug effects. *Cross-sectional study* - A **cross-sectional study** assesses exposure and outcome simultaneously at a single point in time. - This design is suitable for determining **prevalence** but cannot establish temporal relationships between drug exposure and rare adverse effects, nor is it efficient for rare outcomes. *Clinical trial/experimental study* - **Clinical trials** are primarily designed to test the efficacy and safety of new interventions, usually focusing on common adverse effects. - They are generally **not powered** or long enough to detect rare adverse events, as such events would occur in very few participants, if any.
Question 5: In dengue surveillance, indices that are commonly used to monitor Aedes aegypti infestation levels are all, EXCEPT:
- A. Street index (Correct Answer)
- B. House index
- C. Breteau index
- D. Pupae index
Explanation: ***Street index*** - The **Street index** is not a standard entomological index used for monitoring *Aedes aegypti* infestation levels or density in dengue surveillance. - Surveillance efforts typically focus on household-level indices to assess mosquito breeding sites. *House index* - The **House index** (HI) measures the percentage of houses infested with *Aedes* larvae and/or pupae. - It provides an indication of the proportion of dwellings in an area that serve as mosquito breeding sites. *Breteau index* - The **Breteau index** (BI) calculates the number of positive containers per 100 houses inspected. - It reflects the density of breeding containers and is considered a more sensitive indicator of mosquito population density than the House index. *Pupae index* - The **Pupae index** (PI) measures the average number of pupae per person or per house. - This index is highly correlated with adult mosquito density and is considered the most accurate indicator of potential dengue transmission risk.
Question 6: Which of the following statements is true regarding a combined prospective-retrospective study?
- A. Only prospective follow-up from current time point
- B. Retrospective identification of cohort followed by prospective follow-up (Correct Answer)
- C. Cross-sectional assessment at a single time point
- D. Only retrospective data collection from past records
Explanation: ***Retrospective identification of cohort followed by prospective follow-up*** - This correctly describes a **combined prospective-retrospective study** (also called an **ambispective or historical prospective study**) - The study begins by **retrospectively identifying a cohort** from past records (e.g., employees exposed to a chemical 10 years ago) - **Past exposure data is collected retrospectively** from existing records - The identified cohort is then **followed forward prospectively** from the current time point to observe future outcomes - This approach combines the **efficiency of retrospective data collection** with the **rigor of prospective follow-up** *Only prospective follow-up from current time point* - The word **"only"** is the critical error - it excludes the retrospective component - This describes a **purely prospective cohort study**, not a combined study - A combined study must include **both retrospective and prospective elements** *Only retrospective data collection from past records* - This describes a **purely retrospective study** (case-control or retrospective cohort) - It lacks the prospective follow-up component essential to a combined study *Cross-sectional assessment at a single time point* - This defines a **cross-sectional study** that provides a snapshot at one moment - It involves neither retrospective cohort identification nor prospective follow-up
Question 7: Which of the following diseases shows the LEAST difference in incidence between rural and urban populations?
- A. Lung Cancer
- B. TB (Correct Answer)
- C. Bronchitis
- D. Mental illness
Explanation: ***Correct: TB*** - **Tuberculosis (TB)** shows relatively **similar incidence rates** in both rural and urban populations in India, making it the disease with the **LEAST difference** between the two settings. - While urban areas have **overcrowding and slums** as risk factors, rural areas have **poverty, malnutrition, and poor access to healthcare**, which are equally important TB risk factors. - TB is endemic in India across all geographic settings, with the disease burden driven more by **socioeconomic factors** than by rural vs urban location per se. - Both settings face challenges with **poor ventilation** (urban slums vs rural housing), **poverty**, and **inadequate sanitation**. *Incorrect: Lung Cancer* - Lung cancer shows a **clear urban predominance** due to higher exposure to **industrial air pollution**, **vehicular emissions**, and **occupational carcinogens**. - Urban populations historically had higher smoking rates, though this gap is narrowing. - Rural areas have significantly lower lung cancer incidence. *Incorrect: Bronchitis* - Chronic bronchitis is **more common in urban areas** due to **air pollution** from industries and vehicles. - While rural areas may have biomass fuel smoke exposure, the overall incidence of bronchitis shows notable rural-urban differences. - Urban environmental factors contribute to higher prevalence of chronic obstructive airway diseases. *Incorrect: Mental illness* - While mental illness occurs in both settings, there are **differences in types and recognition**. - Urban areas may have higher reported rates due to better access to mental health services and less stigma in seeking care. - Rural areas face challenges with **underdiagnosis** and **limited mental health infrastructure**, making true incidence comparisons difficult.
Question 8: A town in the hills had a mid-year population of 250000 in the year 2021. During the same year, the death registry of the town recorded 1500 deaths due to tuberculosis in 365 calendar days. Given these facts, what is the specific death rate for tuberculosis in the town?
- A. 10
- B. 60
- C. 1
- D. 6 (Correct Answer)
Explanation: ***6*** - The **specific death rate** (also called cause-specific death rate) is calculated as **(Number of deaths from a specific cause / Mid-year population) × 1000** - For tuberculosis: (1500 deaths / 250,000 population) × 1000 = **6 deaths per 1000 population** - This represents the tuberculosis mortality rate in the community *10* - This incorrect value would be obtained if there were 2500 deaths due to tuberculosis instead of 1500 - Calculation error: (2500 / 250,000) × 1000 = 10 - Always verify the numerator (number of deaths) from the given data *60* - This is a common calculation error resulting from incorrect multiplication factor - May occur if using: (1500 / 250,000) × 10,000 = 60 (wrong multiplier) - Remember: specific death rate uses **per 1000** population, not per 10,000 *1* - This value results from calculation errors or incorrect rounding - May occur if dividing by wrong population figure or forgetting the multiplier - The actual rate (1500/250,000 = 0.006) must be multiplied by 1000 to get rate per 1000 population
Question 9: What is the chance of HIV infection after needle prick injury?
- A. 1/300 (Correct Answer)
- B. 1/100
- C. 1/10000
- D. 1 in 1 Lakh
Explanation: ***1/300*** - The risk of **HIV transmission** from a percutaneous exposure (e.g., needlestick) from an HIV-infected source is estimated to be approximately **0.3%**, or **1 in 300** - This is the **established standard risk** based on CDC and WHO occupational safety guidelines - Risk factors that may increase transmission include **deeper injury**, **larger blood volume**, **hollow-bore needle**, **visible blood on device**, and **high viral load** in the source patient *1/100* - This represents a **higher risk (1%)** than typically observed for occupational HIV needlestick injuries - The 1/100 risk is more commonly associated with **Hepatitis C virus (HCV)** transmission after percutaneous exposure, which has significantly higher infectivity than HIV *1/10000* - This represents a **significantly lower risk (0.01%)** than the established average for HIV transmission via needlestick injury - This underestimates the actual occupational risk and could lead to inadequate post-exposure prophylaxis measures *1 in 1 Lakh (1/100,000)* - This represents an **extremely low probability (0.001%)** of transmission, far below the known risk of HIV infection via needlestick - Such a remote risk would be more appropriate for **mucocutaneous exposures** or **intact skin contact**, not percutaneous injuries
Question 10: The incubation period does not help in determining which of the following?
- A. Period of isolation
- B. Immunization (Correct Answer)
- C. Period of quarantine
- D. Identification of source of infection
Explanation: ***Immunization*** - The incubation period provides information about the disease progression from exposure to symptoms but does not directly guide the development or implementation of **immunization strategies**. - Immunization decisions are primarily based on the **disease's epidemiology**, severity, transmissibility, and vaccine efficacy, not the length of a single incubation period. *Period of isolation* - Knowing the incubation period helps determine how long an infected individual should be isolated to prevent transmission. - If the incubation period is short, isolation may be unnecessary, or if long, isolation may need to be prolonged until the infectious period is over. *Period of quarantine* - The incubation period is crucial for setting the duration of quarantine for exposed, but not yet symptomatic, individuals. - Quarantine typically lasts for the maximum incubation period to ensure that a person who develops the disease during this time is not able to transmit it to others. *Identification of source of infection* - By knowing the incubation period, epidemiologists can trace back the potential time of exposure, which is vital for identifying the **source of infection**. - This helps in targeted investigations to prevent further spread from the same source.
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free